Arrowstreet Capital, Limited Partnership Cardiol Therapeutics Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 29,294 shares of CRDL stock, worth $65,911. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,294Holding current value
$65,911% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRDL
# of Institutions
45Shares Held
5.47MCall Options Held
162KPut Options Held
7.4K-
Tejara Capital LTD London, X01.72MShares$3.88 Million1.26% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.47MShares$3.3 Million0.55% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9924KShares$2.08 Million0.36% of portfolio
-
Lion Street Advisors, LLC253KShares$569,8820.19% of portfolio
-
Cambridge Investment Research Advisors, Inc.116KShares$261,2940.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $139M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...